The Global, Regional, and National Disease Burden of Breast Cancer Attributable to Tobacco from 1990 to 2019: a Global Burden of Disease Study

Overview

Journal BMC Public Health

Publisher Biomed Central

Specialty Public Health

Date 2024 Jan 6

PMID 38184557

Authors

Qiusheng Guo

Yunyan Lu

Weiguo Liu

Gaochen Lan

Tian Lan

Affiliations

Soon will be listed here.

Abstract

Objective: Tobacco has been identified as a significant contributory element to the development of breast cancer. Our objective was to evaluate the spatiotemporal trends of tobacco-related breast cancer at the global, regional, and national scales during 1990-2019.

Methods: We extracted data on mortality, disability adjusted of life years (DALYs), age-standardized mortality rate (ASMR), and age-standardized DALYs rate (ASDR) from the Global Burden of Disease (GBD) study 2019. Estimated annual percentage change (EAPC) was computed to assess the temporal change in ASDR and ASMR.

Results: In 2019, the deaths and DALYs attributed to tobacco-related breast cancer were estimated to be 35,439 (95% UI: 22,179-48,119) and 1,060,590 (95% UI: 622,550-1,462,580), respectively. These figures accounted for 5.1% and 5.2% of the total burden of breast cancer. ASMR and ASDR increased in low SDI regions, remained stable in low-middle and middle SDI regions and declined in high and high-middle SDI regions. The burden of breast cancer attributable to tobacco varied notably among regions and nations. Oceania, Southern Latin America, and Central Europe were the GBD regions with the highest number of ASMR and DALYs. There was a positive relationship between age-standardized rate and SDI value in 2019 across 204 nations or territories. A negative association was observed between the EAPC in ASMR or ASDR and the human development index (HDI) in 2019 (R = -0.55, p < 0.01 for ASMR; R = -0.56, p < 0.01 for ASDR).

Conclusion: Tobacco is one important and modifiable risk factor for breast cancer. The heterogeneity in both the spatial and temporal distribution can be attributed to factors such as aging, population growth, and SDI. These findings substantiate the necessity of expediting the enforcement of tobacco-free legislation in order to safeguard populations from the detrimental effects of tobacco.

Citing Articles

Burden and mortality of breast cancer attributed to diabetes and smoking in women: a secondary analysis based on Global Burden of Disease 2019 in North Africa and the Middle East.

Khosravi Shadmani F, Abedi Gheshlaghi L, Jafari-Khounigh A, Rezakhani L, Khazaei M BMJ Open. 2025; 15(1):e087178.

PMID: 39855664 PMC: 11784419. DOI: 10.1136/bmjopen-2024-087178.

Shared genetics between breast cancer and predisposing diseases identifies novel breast cancer treatment candidates.

Lalagkas P, Melamed R Hum Genomics. 2024; 18(1):124.

PMID: 39538313 PMC: 11562851. DOI: 10.1186/s40246-024-00688-4.

Global, reginal, national burden and risk factors in female breast cancer from 1990 to 2021.

Lan T, Lu Y, He J, Zhan C, Wang X, Shao X iScience. 2024; 27(10):111045.

PMID: 39435147 PMC: 11491723. DOI: 10.1016/j.isci.2024.111045.

Global burden and health inequality of nutritional deficiencies from 1990 to 2019.

Yu Y, Li H, Hu N, Wu X, Huang X, Lin H Front Nutr. 2024; 11:1470713.

PMID: 39385781 PMC: 11461340. DOI: 10.3389/fnut.2024.1470713.

Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021.

Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T EClinicalMedicine. 2024; 74:102713.

PMID: 39050105 PMC: 11268131. DOI: 10.1016/j.eclinm.2024.102713.

References

Khodabandeh Z, Valilo M, Velaei K, Pirpour Tazehkand A . The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy. Breast Cancer. 2022; 29(5):778-789. DOI: 10.1007/s12282-022-01369-7. View

Gram I, Wiik A, Lund E, Licaj I, Braaten T . Never-smokers and the fraction of breast cancer attributable to second-hand smoke from parents during childhood: the Norwegian Women and Cancer Study 1991-2018. Int J Epidemiol. 2022; 50(6):1927-1935. PMC: 8743119. DOI: 10.1093/ije/dyab153. View

. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396(10258):1223-1249. PMC: 7566194. DOI: 10.1016/S0140-6736(20)30752-2. View

Hoffman S, Tan C . Overview of systematic reviews on the health-related effects of government tobacco control policies. BMC Public Health. 2015; 15:744. PMC: 4526291. DOI: 10.1186/s12889-015-2041-6. View

Lu Y, Lan T . Global, regional, and national burden of hypertensive heart disease during 1990-2019: an analysis of the global burden of disease study 2019. BMC Public Health. 2022; 22(1):841. PMC: 9044894. DOI: 10.1186/s12889-022-13271-0. View

Di Cello F, Flowers V, Li H, Vecchio-Pagan B, Gordon B, Harbom K . Cigarette smoke induces epithelial to mesenchymal transition and increases the metastatic ability of breast cancer cells. Mol Cancer. 2013; 12:90. PMC: 3750372. DOI: 10.1186/1476-4598-12-90. View

Steinhilper L, Geyer S, Sperlich S . Health behavior change among breast cancer patients. Int J Public Health. 2013; 58(4):603-13. DOI: 10.1007/s00038-013-0444-7. View

Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M . Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022; 66:15-23. PMC: 9465273. DOI: 10.1016/j.breast.2022.08.010. View

Siu A . Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016; 164(4):279-96. DOI: 10.7326/M15-2886. View

10.

Hecht S, Hatsukami D . Smokeless tobacco and cigarette smoking: chemical mechanisms and cancer prevention. Nat Rev Cancer. 2022; 22(3):143-155. PMC: 9308447. DOI: 10.1038/s41568-021-00423-4. View

11.

Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y . Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol. 2019; 12(1):140. PMC: 6925497. DOI: 10.1186/s13045-019-0828-0. View

12.

Pham K, Huynh D, Le L, Delitto D, Yang L, Huang J . E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1. Cancer Lett. 2020; 491:132-145. PMC: 9703643. DOI: 10.1016/j.canlet.2020.08.010. View

13.

He Y, Si Y, Li X, Hong J, Yu C, He N . The relationship between tobacco and breast cancer incidence: A systematic review and meta-analysis of observational studies. Front Oncol. 2022; 12:961970. PMC: 9520920. DOI: 10.3389/fonc.2022.961970. View

14.

Chen T, Kharazmi E, Fallah M . Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening. JAMA Netw Open. 2023; 6(4):e238893. PMC: 10116360. DOI: 10.1001/jamanetworkopen.2023.8893. View

15.

Hopenhayn C, Christian W, Christian A, Studts J, Mullet T . Factors associated with smoking abstinence after diagnosis of early stage lung cancer. Lung Cancer. 2013; 80(1):55-61. DOI: 10.1016/j.lungcan.2012.12.013. View

16.

Raghavendra A, Kypriotakis G, Karam-Hage M, Kim S, Jizzini M, Seoudy K . The Impact of Treatment for Smoking on Breast Cancer Patients' Survival. Cancers (Basel). 2022; 14(6). PMC: 8946483. DOI: 10.3390/cancers14061464. View

17.

Jones M, Schoemaker M, Wright L, Ashworth A, Swerdlow A . Smoking and risk of breast cancer in the Generations Study cohort. Breast Cancer Res. 2017; 19(1):118. PMC: 5698948. DOI: 10.1186/s13058-017-0908-4. View

18.

Skeie G, Hjartaker A, Braaten T, Lund E . Dietary change among breast and colorectal cancer survivors and cancer-free women in the Norwegian Women and Cancer cohort study. Cancer Causes Control. 2009; 20(10):1955-66. DOI: 10.1007/s10552-009-9390-3. View

19.

Makhoul I, Atiq M, Alwbari A, Kieber-Emmons T . Breast Cancer Immunotherapy: An Update. Breast Cancer (Auckl). 2018; 12:1178223418774802. PMC: 5985550. DOI: 10.1177/1178223418774802. View

20.

Ferlay J, Colombet M, Soerjomataram I, Parkin D, Pineros M, Znaor A . Cancer statistics for the year 2020: An overview. Int J Cancer. 2021; . DOI: 10.1002/ijc.33588. View